Cargando…

Molecular Mechanism of Induction of Bone Growth by the C-Type Natriuretic Peptide

The skeletal development process in the body occurs through sequential cellular and molecular processes called endochondral ossification. Endochondral ossification occurs in the growth plate where chondrocytes differentiate from resting, proliferative, hypertrophic to calcified zones. Natriuretic pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rintz, Estera, Węgrzyn, Grzegorz, Fujii, Toshihito, Tomatsu, Shunji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180634/ https://www.ncbi.nlm.nih.gov/pubmed/35682595 http://dx.doi.org/10.3390/ijms23115916

Ejemplares similares

Bone Growth Induction in Mucopolysaccharidosis IVA Mouse
por: Rintz, Estera, et al.
Publicado: (2023)

Promoter considerations in the design of lentiviral vectors for use in treating lysosomal storage diseases
por: Rintz, Estera, et al.
Publicado: (2021)

Ferroptosis and Its Modulation by Autophagy in Light of the Pathogenesis of Lysosomal Storage Diseases
por: Pierzynowska, Karolina, et al.
Publicado: (2021)

Actin Cytoskeleton Polymerization and Focal Adhesion as Important Factors in the Pathomechanism and Potential Targets of Mucopolysaccharidosis Treatment
por: Gaffke, Lidia, et al.
Publicado: (2023)

Mechanism of selective anticancer activity of isothiocyanates relies on differences in DNA damage repair between cancer and healthy cells
por: Hać, Aleksandra, et al.
Publicado: (2019)

Exogenous C-type natriuretic peptide therapy for impaired skeletal growth in a murine model of glucocorticoid treatment
por: Ueda, Yohei, et al.
Publicado: (2019)

Gene Expression-Related Changes in Morphologies of Organelles and Cellular Component Organization in Mucopolysaccharidoses
por: Gaffke, Lidia, et al.
Publicado: (2021)

Activities of (Poly)phenolic Antioxidants and Other Natural Autophagy Modulators in the Treatment of Sanfilippo Disease: Remarkable Efficacy of Resveratrol in Cellular and Animal Models
por: Rintz, Estera, et al.
Publicado: (2022)

Foramen magnum stenosis and midface hypoplasia in C-type natriuretic peptide-deficient rats and restoration by the administration of human C-type natriuretic peptide with 53 amino acids
por: Yotsumoto, Takafumi, et al.
Publicado: (2019)

Circulatory C-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo
por: Kashiwagi, Marina, et al.
Publicado: (2022)

Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses
por: Rintz, Estera, et al.
Publicado: (2020)

Is C-type natriuretic peptide regulated by a feedback loop? A study on systemic and local autoregulatory effect
por: Ueda, Yohei, et al.
Publicado: (2020)

Exogenous C-type natriuretic peptide restores normal growth and prevents early growth plate closure in its deficient rats
por: Hirota, Keisho, et al.
Publicado: (2018)

Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death
por: Fujii, Toshihito, et al.
Publicado: (2018)

Proteasome Composition and Activity Changes in Cultured Fibroblasts Derived From Mucopolysaccharidoses Patients and Their Modulation by Genistein
por: Pierzynowska, Karolina, et al.
Publicado: (2020)

Underestimated Aspect of Mucopolysaccharidosis Pathogenesis: Global Changes in Cellular Processes Revealed by Transcriptomic Studies
por: Gaffke, Lidia, et al.
Publicado: (2020)

Roles of the Oxytocin Receptor (OXTR) in Human Diseases
por: Pierzynowska, Karolina, et al.
Publicado: (2023)

Decreased Levels of Chaperones in Mucopolysaccharidoses and Their Elevation as a Putative Auxiliary Therapeutic Approach
por: Żabińska, Magdalena, et al.
Publicado: (2023)

Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets
por: Leal, Andrés Felipe, et al.
Publicado: (2022)

Glycosaminoglycans as Biomarkers for Mucopolysaccharidoses and Other Disorders
por: Amendum, Paige C., et al.
Publicado: (2021)

Impaired ion homeostasis as a possible associate factor in mucopolysaccharidosis pathogenesis: transcriptomic, cellular and animal studies
por: Gaffke, Lidia, et al.
Publicado: (2021)

C-type natriuretic peptide facilitates autonomic Ca(2+) entry in growth plate chondrocytes for stimulating bone growth
por: Miyazaki, Yuu, et al.
Publicado: (2022)

Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity
por: Yotsumoto, Takafumi, et al.
Publicado: (2019)

Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases
por: Pierzynowska, Karolina, et al.
Publicado: (2018)

Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide
por: Tokudome, Takeshi, et al.
Publicado: (2022)

Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms
por: Gallo, Giovanna, et al.
Publicado: (2023)

C-type natriuretic peptide: the heart’s guardian angel
por: Sangaralingham, S Jeson, et al.
Publicado: (2020)

The Role of Metabolites in the Link between DNA Replication and Central Carbon Metabolism in Escherichia coli
por: Krause, Klaudyna, et al.
Publicado: (2020)

C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and – independent pathways
por: Agoston, Hanga, et al.
Publicado: (2007)

C-type natriuretic peptide and natriuretic peptide receptor B signalling inhibits cardiac sympathetic neurotransmission and autonomic function
por: Buttgereit, Jens, et al.
Publicado: (2016)

C-Type Natriuretic Peptide/Natriuretic Peptide Receptor 2 Is Involved in Cell Proliferation and Testosterone Production in Mouse Leydig Cells
por: Yang, Lei, et al.
Publicado: (2019)

Dexamethasone stimulates expression of C-type Natriuretic Peptide in chondrocytes
por: Agoston, Hanga, et al.
Publicado: (2006)

Physiological and Pathophysiological Effects of C-Type Natriuretic Peptide on the Heart
por: Yasoda, Akihiro
Publicado: (2022)

Natriuretic peptides and cGMP in metabolic disease
por: Collins, Sheila
Publicado: (2015)

C-type Natriuretic Peptide–induced PKA Activation Promotes Endochondral Bone Formation in Hypertrophic Chondrocytes
por: Hirota, Keisho, et al.
Publicado: (2022)

Heads and Tails of Natriuretic Peptides: Neuroprotective Role of Brain Natriuretic Peptide
por: Fernández‐Susavila, Héctor, et al.
Publicado: (2017)

Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide
por: Khambata, Rayomand S, et al.
Publicado: (2011)

Snake venom natriuretic peptides: Potential molecular probes
por: Sridharan, Sindhuja, et al.
Publicado: (2015)

ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism
por: Morozumi, Naomi, et al.
Publicado: (2019)

Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis
por: Pandey, Kailash N.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_meor8uohbncknljao6o50ar6r7